Ramkhamhaeng Hospital PCL (BKK:RAM)
Thailand · Delayed Price · Currency is THB 18.40
0.00 (0.00%)
Jun 2, 2026, 4:29 PM ICT
Ramkhamhaeng Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17,451 | 14,752 | 9,868 | 9,634 | 10,687 | 12,664 | |
Revenue Growth (YoY) | 71.98% | 49.50% | 2.42% | -9.85% | -15.62% | 61.83% |
Cost of Revenue | 13,270 | 11,179 | 7,532 | 7,461 | 7,810 | 7,941 |
Gross Profit | 4,182 | 3,573 | 2,336 | 2,174 | 2,876 | 4,723 |
Selling, General & Admin | 2,781 | 2,242 | 1,360 | 1,520 | 1,513 | 1,364 |
Operating Expenses | 2,888 | 2,349 | 1,441 | 1,559 | 1,513 | 1,364 |
Operating Income | 1,294 | 1,224 | 894.63 | 614.3 | 1,363 | 3,359 |
Interest Expense | -511.34 | -473.61 | -428.72 | -332.3 | -243.38 | -239.31 |
Interest & Investment Income | 1,808 | 1,872 | 267.99 | 296.43 | 355.19 | 316.5 |
Earnings From Equity Investments | 664.99 | 696.94 | 56.81 | 707.72 | 1,002 | 2,259 |
Other Non Operating Income (Expenses) | 200.51 | 163.15 | 108.83 | 92.65 | 102.12 | 79.51 |
EBT Excluding Unusual Items | 3,456 | 3,482 | 899.53 | 1,379 | 2,579 | 5,775 |
Gain (Loss) on Sale of Investments | 22.66 | 22.66 | - | 313.89 | 84.12 | 122.15 |
Gain (Loss) on Sale of Assets | -15.28 | -15.28 | -15.55 | 1.13 | 0.48 | - |
Pretax Income | 3,464 | 3,490 | 883.98 | 1,694 | 2,664 | 5,897 |
Income Tax Expense | 468.18 | 442.11 | 191.23 | 271.03 | 275.04 | 506.33 |
Earnings From Continuing Operations | 2,995 | 3,048 | 692.75 | 1,423 | 2,389 | 5,391 |
Minority Interest in Earnings | -296.76 | -249.75 | 35.08 | 128.43 | -214.83 | -1,220 |
Net Income | 2,699 | 2,798 | 727.83 | 1,551 | 2,174 | 4,171 |
Net Income to Common | 2,699 | 2,798 | 727.83 | 1,551 | 2,174 | 4,171 |
Net Income Growth | 270.25% | 284.40% | -53.08% | -28.64% | -47.89% | 228.15% |
Shares Outstanding (Basic) | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
Shares Outstanding (Diluted) | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
EPS (Basic) | 2.25 | 2.33 | 0.61 | 1.29 | 1.81 | 3.48 |
EPS (Diluted) | 2.25 | 2.33 | 0.61 | 1.29 | 1.81 | 3.48 |
EPS Growth | 270.25% | 284.40% | -53.08% | -28.64% | -47.89% | 228.15% |
Free Cash Flow | 1,101 | 1,060 | -35.6 | -259.77 | 631.6 | 2,413 |
Free Cash Flow Per Share | 0.92 | 0.88 | -0.03 | -0.22 | 0.53 | 2.01 |
Dividend Per Share | 0.100 | 0.100 | 0.400 | 0.900 | 1.100 | 0.760 |
Dividend Growth | -50.00% | -75.00% | -55.56% | -18.18% | 44.74% | 5.56% |
Gross Margin | 23.96% | 24.22% | 23.67% | 22.56% | 26.91% | 37.30% |
Operating Margin | 7.41% | 8.30% | 9.07% | 6.38% | 12.76% | 26.52% |
Profit Margin | 15.46% | 18.97% | 7.38% | 16.10% | 20.34% | 32.94% |
Free Cash Flow Margin | 6.31% | 7.18% | -0.36% | -2.70% | 5.91% | 19.05% |
EBITDA | 2,946 | 2,580 | 1,896 | 1,586 | 2,315 | 4,144 |
EBITDA Margin | 16.88% | 17.49% | 19.21% | 16.46% | 21.66% | 32.72% |
D&A For EBITDA | 1,652 | 1,356 | 1,001 | 971.54 | 951.2 | 784.55 |
EBIT | 1,294 | 1,224 | 894.63 | 614.3 | 1,363 | 3,359 |
EBIT Margin | 7.41% | 8.30% | 9.07% | 6.38% | 12.76% | 26.52% |
Effective Tax Rate | 13.52% | 12.67% | 21.63% | 16.00% | 10.33% | 8.59% |
Revenue as Reported | 19,465 | 16,792 | 10,229 | 10,334 | 11,219 | 13,218 |
Advertising Expenses | - | 124.7 | 53.38 | 48.18 | 66.26 | 67.88 |